0.000USD0.000Pre-market 07/27, 09:30 (ET)
52.27MMarket Cap
LossP/E TTM
CTOR Financials
See Citius Oncology Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.
Citius Oncology Inc Earnings Date
Latest Release
May 15, 2026
EPS / Forecast
-0.27/-0.01
Revenue / Forecast
1.67M/7.00M
Analyst Rating
BUY
2026/07/26
FAQs
What are the current assets of Citius Oncology Inc?
According to Citius Oncology Inc's FY2025 earnings report, its current assets were 27.54M, with a year-on-year change of 151.10.
What are the total assets of Citius Oncology Inc?
According to Citius Oncology Inc's FY2025 earnings report, its total assets of Citius Oncology Inc were 100.94M, with a year-on-year change of 19.64.
What are the total liabilities of Citius Oncology Inc?
According to Citius Oncology Inc's FY2025 earnings report, its total liabilities of Citius Oncology Inc were 56.08M, with a year-on-year change of 46.69.
What is the total equity of Citius Oncology Inc?
According to Citius Oncology Inc's FY2025 earnings report, its total equity of Citius Oncology Inc was 44.87M, with a year-on-year change of -2.76.
What is the net operating income of Citius Oncology Inc?
According to Citius Oncology Inc's FY2025 earnings report, its net operating income of Citius Oncology Inc was -23.52M, with a year-on-year change of -14.34.
What is the net investment of Citius Oncology Inc?
According to Citius Oncology Inc's FY2025 earnings report, its net investment of Citius Oncology Inc was -5.75M, with a year-on-year change of -15.00.
What is the net financing of Citius Oncology Inc?
According to Citius Oncology Inc's FY2025 earnings report, its net financing of Citius Oncology Inc was 15.17M, with a year-on-year change of 211.19.
What is the Earnings Per Share (EPS) of Citius Oncology Inc?
According to Citius Oncology Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.34, with a year-on-year change of -8.75.
What is the net income of Citius Oncology Inc?
According to Citius Oncology Inc's FY2025 earnings report, its net income was -24.76M, with a year-on-year change of -17.08.
What is the debt-to-asset ratio of Citius Oncology Inc?
According to Citius Oncology Inc's FY2025 earnings report, its debt-to-asset ratio was 3.76, with a year-on-year change of -16.42.
What is the Return on Equity (ROE) of Citius Oncology Inc?
According to Citius Oncology Inc's FY2025 earnings report, its Return on Equity (ROE) was -54.42, with a year-on-year change of 7.79.
What is the Return on Assets (ROA) of Citius Oncology Inc?
According to Citius Oncology Inc's FY2025 earnings report, its Return on Assets (ROA) was -26.72, with a year-on-year change of 16.54.
What is the operating profit of Citius Oncology Inc?
According to Citius Oncology Inc's FY2025 earnings report, its operating profit was -23.52M, with a year-on-year change of -14.34.